Skip to content

Capital Market Strategies LLC: ROE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Capital Market Strategies LLC on ROE, newest first. How the timeline and the estimate are built.

Capital Market Strategies LLC held 25,259 ROE shares at 2025-06-30 per its 13F-HR filed 2025-07-02.

the latest 13F is the newest step

  1. period ended2025-06-30
    13F 25,259 shares
    Change vs previous 13F -3,185 shares

    0.57% of the 13F portfolio, value $813,592.

    13F-HR 0001810158-25-000004 filed by Capital Market Strategies LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2025-03-31
    13F 28,444 shares
    Change vs previous 13F +275 shares

    0.56% of the 13F portfolio, value $832,556.

    13F-HR 0001810158-25-000002 filed by Capital Market Strategies LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2024-12-31
    13F 28,169 shares
    Change vs previous 13F +1,576 shares

    0.49% of the 13F portfolio, value $856,338.

    13F-HR 0001810158-25-000001 filed by Capital Market Strategies LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-09-30
    13F 26,593 shares
    Change vs previous 13F +9,555 shares

    0.49% of the 13F portfolio, value $819,181.

    13F-HR 0001810158-24-000004 filed by Capital Market Strategies LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-06-30
    13F 17,038 shares
    Change vs previous 13F not available

    0.31% of the 13F portfolio, value $495,470.

    13F-HR 0001810158-24-000003 filed by Capital Market Strategies LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).